Zhenling Li

698 total citations
40 papers, 465 citations indexed

About

Zhenling Li is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Zhenling Li has authored 40 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 14 papers in Hematology and 10 papers in Genetics. Recurrent topics in Zhenling Li's work include Acute Myeloid Leukemia Research (8 papers), Multiple Myeloma Research and Treatments (6 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers). Zhenling Li is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), Multiple Myeloma Research and Treatments (6 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers). Zhenling Li collaborates with scholars based in China, Hong Kong and South Korea. Zhenling Li's co-authors include Chao Guo, Ming Gong, Zhenhua Lin, Chunxia Zhang, Qianqian Ju, Peng Qi, Yue Zhang, Guanghai Yan, Tiefeng Jin and Lijuan Lin and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Food Chemistry.

In The Last Decade

Zhenling Li

36 papers receiving 462 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhenling Li China 14 280 98 63 56 47 40 465
Linyi Liu China 14 191 0.7× 27 0.3× 72 1.1× 48 0.9× 13 0.3× 31 395
Ludmila de Faro Valverde Brazil 14 229 0.8× 48 0.5× 115 1.8× 8 0.1× 32 0.7× 31 451
Chun‐Wen Su Taiwan 13 316 1.1× 168 1.7× 101 1.6× 15 0.3× 21 0.4× 24 486
Long Ma China 11 221 0.8× 36 0.4× 136 2.2× 36 0.6× 12 0.3× 25 522
Manman Deng China 15 342 1.2× 90 0.9× 141 2.2× 170 3.0× 12 0.3× 42 556
Samantha A. Streicher United States 5 374 1.3× 70 0.7× 233 3.7× 21 0.4× 20 0.4× 9 563
Miaorong She China 10 254 0.9× 48 0.5× 118 1.9× 51 0.9× 11 0.2× 15 389
Xin Jing China 12 305 1.1× 106 1.1× 173 2.7× 19 0.3× 21 0.4× 28 554
Iryna Kolosenko Sweden 11 237 0.8× 91 0.9× 116 1.8× 43 0.8× 8 0.2× 19 383

Countries citing papers authored by Zhenling Li

Since Specialization
Citations

This map shows the geographic impact of Zhenling Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenling Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenling Li more than expected).

Fields of papers citing papers by Zhenling Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenling Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenling Li. The network helps show where Zhenling Li may publish in the future.

Co-authorship network of co-authors of Zhenling Li

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenling Li. A scholar is included among the top collaborators of Zhenling Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenling Li. Zhenling Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yuan, Mengyao, Yanli Zhang, Bingcheng Liu, et al.. (2025). Treatment‐free remission in chronic myeloid leukaemia patients with accelerated phase or tyrosine kinase inhibitor therapy failure. British Journal of Haematology. 207(4). 1408–1415. 1 indexed citations
2.
Wang, Ting, Chunli Zhang, Yanping Ding, et al.. (2024). BCMA-BBZ-OX40 CAR-T Therapy Using an Instant Manufacturing Platform in Multiple Myeloma. Journal for ImmunoTherapy of Cancer. 12(9). e009476–e009476. 4 indexed citations
3.
4.
5.
Shi, Yuankai, Lin Gui, Ying Cheng, et al.. (2024). A phase II multicenter study of abexinostat, an oral histone deacetylase inhibitor, in patients with relapsed/refractory follicular lymphoma.. Journal of Clinical Oncology. 42(16_suppl). 7059–7059. 2 indexed citations
6.
Yang, Ping, Qingqing Cai, Wei Zhang, et al.. (2023). Real‐world treatment and outcome patterns of patients with mantle cell lymphoma in China: A large, multicenter retrospective analysis. Cancer Medicine. 12(12). 13204–13216. 5 indexed citations
7.
Lyu, Xiaodong, Dandan Zhu, Yan Chen, et al.. (2022). Whole-genome sequencing as an alternative to analyze copy number abnormalities in acute myeloid leukemia and myelodysplastic syndrome. Leukemia & lymphoma. 63(10). 2301–2310.
8.
Guo, Chao, Qianqian Ju, Min Wang, et al.. (2021). MAPK14 over-expression is a transcriptomic feature of polycythemia vera and correlates with adverse clinical outcomes. Journal of Translational Medicine. 19(1). 233–233. 1 indexed citations
9.
Guo, Chao, et al.. (2021). HELQ and EGR3 expression correlate with IGHV mutation status and prognosis in chronic lymphocytic leukemia. Journal of Translational Medicine. 19(1). 42–42. 4 indexed citations
10.
Guo, Chao, et al.. (2021). The landscape of gene co-expression modules correlating with prognostic genetic abnormalities in AML. Journal of Translational Medicine. 19(1). 228–228. 25 indexed citations
11.
Guo, Chao, et al.. (2020). LINC00649 underexpression is an adverse prognostic marker in acute myeloid leukemia. BMC Cancer. 20(1). 841–841. 33 indexed citations
12.
Guo, Chao, Ming Gong, & Zhenling Li. (2020). <p>Knockdown of lncRNA MCM3AP-AS1 Attenuates Chemoresistance of Burkitt Lymphoma to Doxorubicin Treatment via Targeting the miR-15a/EIF4E Axis</p>. Cancer Management and Research. Volume 12. 5845–5855. 20 indexed citations
13.
Guo, Chao, et al.. (2020). Overexpression of HOXA10 is associated with unfavorable prognosis of acute myeloid leukemia. BMC Cancer. 20(1). 586–586. 20 indexed citations
14.
15.
Cui, Xuelian, et al.. (2017). Mortalin expression in pancreatic cancer and its clinical and prognostic significance. Human Pathology. 64. 171–178. 23 indexed citations
16.
Zhang, Li, Hong Shen, Jun Xu, et al.. (2017). UPLC-QTOF-MS/MS-guided isolation and purification of sulfur-containing derivatives from sulfur-fumigated edible herbs, a case study on ginseng. Food Chemistry. 246. 202–210. 32 indexed citations
17.
Lin, Lijuan, Jie Sun, Yan Tan, et al.. (2017). Prognostic implication of NQO1 overexpression in hepatocellular carcinoma. Human Pathology. 69. 31–37. 45 indexed citations
18.
Zhang, Chunxia, Li Gao, Qianqian Ju, et al.. (2015). Symptom burden and its relationships with risk assessment and gene mutations in patients with primary myelofibrosis. 24(8). 453–456. 1 indexed citations
19.
Li, Zhenling, Yue Zhang, Tiefeng Jin, et al.. (2015). NQO1 protein expression predicts poor prognosis of non-small cell lung cancers. BMC Cancer. 15(1). 207–207. 82 indexed citations
20.
Liu, Jian, Junhong Leng, Chen Tang, et al.. (2014). Maternal glucose level and body mass index measured at gestational diabetes mellitus screening and the risk of macrosomia: results from a perinatal cohort study. BMJ Open. 4(5). e004538–e004538. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Linyi Liu Breakdown of academic impact, for papers by Ludmila de Faro Valverde Breakdown of academic impact, for papers by Chun‐Wen Su Breakdown of academic impact, for papers by Long Ma Breakdown of academic impact, for papers by Manman Deng Breakdown of academic impact, for papers by Samantha A. Streicher Breakdown of academic impact, for papers by Miaorong She Breakdown of academic impact, for papers by Xin Jing Breakdown of academic impact, for papers by Iryna Kolosenko
Rankless by CCL
2026